Ceribell Inc., based in Sunnyvale, California, has developed a point-of-care EEG system that provides real-time seizure monitoring and alerting, which helps in the rapid and precise treatment of patients with suspected non-convulsive seizures. The FDA-cleared Ceribell ClarityPro software uses a machine-learning model to analyze EEG signals and generate bedside alerts.

The FDA approved the cannabis-based drug for treating seizures in two severe forms of epilepsy.

By passively collecting seizure data, Empatica’s device could help patients share medical information with clinicians and make that data easier to manage.